Skip to content

Clinical trials

Completed Multiple Sclerosis trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Status: Completed Country / region: Norway Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20064
20074
20083
20091
20103
20113
20121
20133
20161
20171
20182
20193
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Novartis Pharmaceuticals5
Biogen4
Sanofi4
GlaxoSmithKline3
EMD Serono Research & Development Institute, Inc.2
Merck KGaA, Darmstadt, Germany2
Otivio AS2
EMD Serono1
Haukeland University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis34
Multiple Sclerosis, Relapsing-Remitting5
Muscle Spasticity2
Pain2
Demyelinating Diseases1
Diffuse Cerebral Sclerosis of Schilder1
Disease Progression1
Fatigue1
Neuromyelitis Optica1
Osteoporosis1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.